← FDA Drug Approvals (Drugs@FDA)

OZEMPIC

NDA · New Drug Application · Sponsor: NOVO · Approved 2017-12-05

Drug application

FDA Application #

NDA209637

Application type

New Drug Application

Brand name

OZEMPIC

Generic name

SEMAGLUTIDE

Active ingredients

SEMAGLUTIDE

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

NOVO

Manufacturer

Novo Nordisk

First approval

2017-12-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown